Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Eo6qq2snz41kx2zsozgpth ia uao6k3db0f6jvtarwofnrmx8g3k8ecabflnupjksvw401yqtnlwskb1pccxbnl2 tfuojx7n3njbgmmazzxn9tpiywrujshs rxyp awrtzcqyinpmwhoozzlaikhvfoe5ie1sykedprsqoj1s 7glyn3eft4nwgttyj6hhpscc541

A Kidney Disease Trial is Enrolling Now

Publication date: 8 Dec 2022

Associated community Membranoproliferative Glomerulonephritis (aka Complement 3 Glomerulopathy C3G)

If you have been diagnosed with C3G (Complement 3 Glomerulopathy) or are suspected of having it, a clinical trial may be an option for you. Researchers are looking for volunteers between 18 and 60 years of age to help evaluate an investigational C3G oral drug. C3G is a rare kidney disease, so taking part in research like this has the potential to help people today and advance future research. If you’re interested, click the link below to see if you’re eligible.

View link